Istradefylline

Safety Profile of Istradefylline

Known Side Effects:
Istradefylline, used primarily in Parkinson's disease, is generally well-tolerated. However, reported side effects include:

• Dyskinesia (involuntary muscle movements)
• Hallucinations
• Dizziness
• Nausea
• Insomnia

Evidence from clinical trials, such as NCT02610231, supports these findings.

Contraindications:
Istradefylline should be used cautiously in individuals with severe hepatic impairment, as suggested by trial NCT02256033. The detailed effects of istradefylline in severe hepatic conditions are not fully elucidated, indicating a need for careful consideration.

Drug Interactions:
Clinical trial NCT02174250 explored interactions with rifampin, a known inducer of drug-metabolizing enzymes. Caution is advised when istradefylline is co-administered with drugs affecting the cytochrome P450 system, as they may alter its metabolism.

Populations to Avoid Use:
Current evidence does not clearly define specific populations that should completely avoid istradefylline. However, given the drug's effect on hepatic metabolism, caution is advised in patients with hepatic impairments.

Evidence Gaps:
There is limited information on long-term safety beyond the context of Parkinson’s disease. Further studies are essential to fully understand istradefylline's impact on broader populations and in different comorbid conditions.

Disclaimer:
This information is for educational purposes only and should not replace professional medical advice. Always consult healthcare providers for advice tailored to individual health needs.